India to Philippines: Temozolomide Export Trade Route
India has recorded 30 verified shipments of Temozolomide exported to Philippines, representing a combined trade value of $437.0K USD. This corridor is served by 8 active Indian exporters, with an average shipment value of $14.6K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 66% of total export value with 4 shipments worth $288.7K USD. On the buying side, SUN PHARMA PHILIPPINES INC. is the largest importer in Philippines with $288.7K USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , VEXXA LIFESCIENCES PVT. LTD. — together control 97% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Philippines Temozolomide corridor is one of India's established pharmaceutical export routes, with 30 shipments documented worth a combined $437.0K USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 66% of all export value, reflecting the consolidated nature of India's temozolomide manufacturing sector.
Across 8 active suppliers, the average shipment value stands at $14.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with temozolomide's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 15.6%, placing it at rank #20 among India's top temozolomide export destinations globally.
On the import side, key buyers of Indian temozolomide in Philippines include SUN PHARMA PHILIPPINES INC., SUN PHARMA PHILIPPINES INC. , VE PHARMA INC and 5 others. SUN PHARMA PHILIPPINES INC. is the single largest importer with 4 shipments valued at $288.7K USD.
Route Characteristics
- Average transit21 days
- Peak seasonQ2
- Primary modeSea freight
- Top portDELHI AIR CARGO ACC (INDEL4)
Market Position
- Global rank#20
- Annual growth+15.6%
- Demand growth+13.6%
- Regulatory ease85/100
Top 10 Indian Temozolomide Exporters to Philippines
Showing top 10 of 8 Indian suppliers exporting Temozolomide to Philippines, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $72.2K per shipment | 4 | $288.7K | 66.1% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $38.6K per shipment | 3 | $115.8K | 26.5% |
| 3 | VEXXA LIFESCIENCES PVT. LTD. Avg $1.7K per shipment | 11 | $18.4K | 4.2% |
| 4 | VEXXA LIFESCIENCES PVT. LTD. Avg $1.7K per shipment | 4 | $6.8K | 1.6% |
| 5 | VEXXA LIFESCIENCES PRIVATE LIMITED Avg $1.5K per shipment | 4 | $5.9K | 1.4% |
| 6 | MALLESHWAR SPECIALITIES Avg $329 per shipment | 2 | $659 | 0.2% |
| 7 | VEXXA LIFESCIENCES PVT LTD Avg $479 per shipment | 1 | $479 | 0.1% |
| 8 | SANSKRUTI PHARMA Avg $285 per shipment | 1 | $285 | 0.1% |
This table shows the top 10 of 8 Indian companies exporting temozolomide to Philippines, ranked by total trade value. The listed exporters are: SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , VEXXA LIFESCIENCES PVT. LTD., VEXXA LIFESCIENCES PVT. LTD. , VEXXA LIFESCIENCES PRIVATE LIMITED, MALLESHWAR SPECIALITIES, VEXXA LIFESCIENCES PVT LTD, SANSKRUTI PHARMA. SUN PHARMACEUTICAL INDUSTRIES LIMITED is the dominant supplier with 4 shipments worth $288.7K USD, giving it a 66% market share. The top 3 suppliers together account for 97% of the total trade value on this route.
Top 10 Temozolomide Importers in Philippines
Showing top 10 of 8 known buyers in Philippines receiving Temozolomide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian temozolomide in Philippines include SUN PHARMA PHILIPPINES INC., SUN PHARMA PHILIPPINES INC. , VE PHARMA INC, Ve Pharma Inc. , Ve Pharma Inc., among 8 total buyers. The largest importer is SUN PHARMA PHILIPPINES INC., accounting for $288.7K USD across 4 shipments — representing 66% of all temozolomide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMA PHILIPPINES INC. | 4 | $288.7K | 66.1% |
| 2 | SUN PHARMA PHILIPPINES INC. | 3 | $115.8K | 26.5% |
| 3 | VE PHARMA INC | 13 | $18.0K | 4.1% |
| 4 | Ve Pharma Inc. | 4 | $6.8K | 1.6% |
| 5 | Ve Pharma Inc. | 2 | $5.1K | 1.2% |
| 6 | VE PHARMA INC. | 1 | $1.7K | 0.4% |
| 7 | RENATO C LOZADA | 2 | $659 | 0.2% |
| 8 | CLIENT CODE PH001, | 1 | $285 | 0.1% |
Top 10 Temozolomide Formulations Imported by Philippines
Showing top 10 of 26 product formulations shipped on the India to Philippines Temozolomide route, ranked by trade value
Philippines imports a wide range of temozolomide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — GLIOTEM 100 CAPSULES (TEMOZOLOMIDE CAPSULES 100 MG) — accounts for $147.6K USD across 1 shipments. There are 26 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | GLIOTEM 100 CAPSULES (TEMOZOLOMIDE CAPSULES 100 MG) | 1 | $147.6K | 33.8% |
| 2 | GLIOTEM 100 CAPSULES (TEMOZOLOMIDE CAPSULES 100 MG ) | 1 | $102.1K | 23.4% |
| 3 | GLIOTEM 100 CAPSULES (TEMOZOLOMIDE CAPSU | 1 | $88.1K | 20.2% |
| 4 | GLIOTEM 20 CAPSULES (TEMOZOLOMIDE CAPSULES 20 MG) | 1 | $24.9K | 5.7% |
| 5 | GLIOTEM 20 CAPSULES(TEMOZOLOMIDE CAPSULE | 1 | $18.2K | 4.2% |
| 6 | GLIOTEM 20 CAPSULES (TEMOZOLOMIDE CAPSULE 20 MG ) | 1 | $14.2K | 3.2% |
| 7 | GLIOTEM 20 CAPSULES (TEMOZOLOMIDE CAPSUL | 1 | $9.5K | 2.2% |
| 8 | Temovex 100 (TEMOZOLOMIDE CAPSULES 100 M | 4 | $6.8K | 1.6% |
| 9 | Temovex 100 TEMOZOLOMIDE CAPSULES 100 | 1 | $3.4K | 0.8% |
| 10 | Temovex 100 (TEMOZOLOMIDE CAPSULES 100 | 1 | $3.4K | 0.8% |
Showing top 10 of 26 Temozolomide formulations imported by Philippines on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 81%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR CARGO ACC (INDEL4) handles the highest volume with 9 shipments. Transit time averages 21 days by sea.
Market Dynamics
India's temozolomide exports to Philippines are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , VEXXA LIFESCIENCES PVT. LTD. — together account for 97% of total trade value on this route. The average shipment value of $14.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as gliotem 100 capsules (temozolomide capsules 100 mg ) and gliotem 100 capsules (temozolomide capsu , suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, SUN PHARMA PHILIPPINES INC. is the largest importer with 4 shipments worth $288.7K USD — representing 66% of all temozolomide imports from India on this route. A total of 8 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $437.0K
- Avg. Shipment
- $14.6K
- Suppliers
- 8
- Buyers
- 8
- Transit (Sea)
- ~21 days
- Annual Growth
- +15.6%
Related Analysis
Other Temozolomide Routes
Unlock the Full India to Philippines Temozolomide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 30 shipments on this route.
Frequently Asked Questions — India to Philippines Temozolomide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Temozolomide to Philippines?
The leading Indian exporters of Temozolomide to Philippines are SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , VEXXA LIFESCIENCES PVT. LTD.. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest market share at approximately 66% of total trade value on this route.
Q What is the total value of Temozolomide exports from India to Philippines?
India exports Temozolomide to Philippines worth approximately $437.0K USD across 30 recorded shipments. The average value per shipment is $14.6K USD.
Q Which ports does India use to ship Temozolomide to Philippines?
The most active port of origin is DELHI AIR CARGO ACC (INDEL4) with 9 shipments. Indian exporters primarily use sea freight for this route, with 81% of shipments going by sea and 27% by air.
Q How long does shipping take from India to Philippines for Temozolomide?
The average transit time for Temozolomide shipments from India to Philippines is approximately 21 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Philippines Temozolomide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 15.6% with demand growth tracking at 13.6%. The route is ranked #20 among India's top Temozolomide export destinations globally.
Q How many suppliers are active on the India to Philippines Temozolomide route?
There are currently 8 active Indian suppliers exporting Temozolomide to Philippines. The market is moderately concentrated with SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 66% of total shipment value.
Q Who are the main importers of Temozolomide from India in Philippines?
The leading importers of Indian Temozolomide in Philippines include SUN PHARMA PHILIPPINES INC., SUN PHARMA PHILIPPINES INC. , VE PHARMA INC, Ve Pharma Inc. , Ve Pharma Inc.. SUN PHARMA PHILIPPINES INC. is the largest buyer with 4 shipments worth $288.7K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Philippines export trade corridor identified from Indian Customs (DGFT) records for Temozolomide.
- 2.Supplier/Buyer Matching: 8 Indian exporters and 8 importers in Philippines matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 30 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
30 Verified Shipments
8 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists